The PD-L2/PD-1 interaction has a higher affinity for cancer cells than the differentiated PD-L1/PD-1 interaction and activation; however, the tumor expression and activity of differentiated PD-L2 in regulatory cancer cells is much less than that of PD-L1 (12). The gene discussed is PDCD1LG2; the disease is cancer.